X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with Divis Laboratories - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs DIVIS LABORATORIES - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD DIVIS LABORATORIES WYETH LTD/
DIVIS LABORATORIES
 
P/E (TTM) x 27.7 18.8 147.7% View Chart
P/BV x 5.3 4.1 131.7% View Chart
Dividend Yield % 1.3 1.5 83.6%  

Financials

 WYETH LTD   DIVIS LABORATORIES
EQUITY SHARE DATA
    WYETH LTD
Mar-13
DIVIS LABORATORIES
Mar-16
WYETH LTD/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,0442,484 42.1%   
Low Rs818918 89.1%   
Sales per share (Unadj.) Rs298.6142.3 209.9%  
Earnings per share (Unadj.) Rs57.241.9 136.7%  
Cash flow per share (Unadj.) Rs58.446.3 126.1%  
Dividends per share (Unadj.) Rs17.0010.00 170.0%  
Dividend yield (eoy) %1.80.6 310.5%  
Book value per share (Unadj.) Rs249.5161.5 154.5%  
Shares outstanding (eoy) m22.72265.47 8.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.112.0 26.1%   
Avg P/E ratio x16.340.6 40.1%  
P/CF ratio (eoy) x15.936.7 43.4%  
Price / Book Value ratio x3.710.5 35.4%  
Dividend payout %29.723.9 124.4%   
Avg Mkt Cap Rs m21,157451,525 4.7%   
No. of employees `0000.53.7 13.3%   
Total wages/salary Rs m4003,649 11.0%   
Avg. sales/employee Rs Th13,787.410,184.4 135.4%   
Avg. wages/employee Rs Th813.0984.1 82.6%   
Avg. net profit/employee Rs Th2,643.32,998.5 88.2%   
INCOME DATA
Net Sales Rs m6,78337,764 18.0%  
Other income Rs m353848 41.6%   
Total revenues Rs m7,13638,612 18.5%   
Gross profit Rs m1,61714,138 11.4%  
Depreciation Rs m271,182 2.3%   
Interest Rs m623 23.7%   
Profit before tax Rs m1,93813,781 14.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m6322,662 23.7%   
Profit after tax Rs m1,30111,119 11.7%  
Gross profit margin %23.837.4 63.7%  
Effective tax rate %32.619.3 168.9%   
Net profit margin %19.229.4 65.1%  
BALANCE SHEET DATA
Current assets Rs m6,98430,947 22.6%   
Current liabilities Rs m2,0565,195 39.6%   
Net working cap to sales %72.668.2 106.5%  
Current ratio x3.46.0 57.0%  
Inventory Days Days99117 85.0%  
Debtors Days Days2485 28.1%  
Net fixed assets Rs m24417,027 1.4%   
Share capital Rs m227531 42.8%   
"Free" reserves Rs m5,44142,341 12.9%   
Net worth Rs m5,66842,877 13.2%   
Long term debt Rs m255 531.9%   
Total assets Rs m7,90149,684 15.9%  
Interest coverage x353.3595.0 59.4%   
Debt to equity ratio x00 4,023.8%  
Sales to assets ratio x0.90.8 113.0%   
Return on assets %16.522.4 73.7%  
Return on equity %22.925.9 88.5%  
Return on capital %34.032.2 105.8%  
Exports to sales %0.285.3 0.3%   
Imports to sales %36.322.9 158.6%   
Exports (fob) Rs m1532,198 0.0%   
Imports (cif) Rs m2,4658,654 28.5%   
Fx inflow Rs m1532,270 0.0%   
Fx outflow Rs m2,6778,775 30.5%   
Net fx Rs m-2,66223,496 -11.3%   
CASH FLOW
From Operations Rs m92310,379 8.9%  
From Investments Rs m317-4,135 -7.7%  
From Financial Activity Rs m-481-6,241 7.7%  
Net Cashflow Rs m7593 23,003.0%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 11.8 95.8%  
FIIs % 7.2 19.0 37.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 17.2 176.7%  
Shareholders   21,978 31,796 69.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   GLENMARK PHARMA  J.B.CHEMICALS  MERCK LTD  BIOCON LTD  FULFORD INDIA  

Compare WYETH LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens in Green; Tata Stocks in Focus(09:30 am)

Asian stock indices are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.13% while the Hang Seng is down 0.54%. The Shanghai Composite is trading down by 0.02%.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD - TTK HEALTHCARE COMPARISON

COMPARE WYETH LTD WITH

MARKET STATS